uniQure N.V. - Ordinary Shares (QURE) Social Stream



uniQure N.V. - Ordinary Shares (QURE): $20.45

1.27 (+6.62%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add QURE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

uniQure NV (QURE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering uniQure NV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 15 $95 $40 $67.916 $20.45 232.11%
2021-12-10 14 $95 $40 $68 $20.45 232.52%
2021-12-17 14 $95 $40 $66.416 $20.45 224.77%
2022-03-01 13 $95 $40 $66.363 $20.45 224.51%
2022-03-17 13 $95 $40 $66.363 $20.45 224.51%
2022-03-29 13 $95.001 $40 $66.363 $20.45 224.51%
2022-03-30 13 $90 $40 $64.8 $20.45 216.87%

The Trend in the Analyst Price Target


QURE's average price target has moved down $22.05 over the prior 22 months.

Over the past 50 weeks, QURE's average upside potential has been 161.51%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 17 100.000 40 68.530 35.32 94.03%
2021-06-21 18 100.000 40 67.290 32.84 104.9%
2021-07-03 18 100.000 40 67.570 30.50 121.54%
2021-08-07 18 95.000 40 66.970 30.52 119.43%
2022-03-29 13 95.001 40 66.363 17.80 272.83%

QURE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.08 12 1 0 0 0 13

The Trend in the Broker Recommendations


QURE's average broker recommendation rating improved by 0.05 over the prior 120 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • QURE has a greater upside potential (average analyst target price relative to current price) than 810.56% of all US stocks.
  • uniQure NV's number of analysts covering the stock is greater than 862.04% of stocks in the mid market cap category.
  • In the context of stocks in the mid market cap category, uniQure NV's variance in analysts' estimates is lower than -676.89% of them.
  • In the context of Pharmaceutical Products stocks, uniQure NV's average analyst price target is greater than 700.91% of them.

Stocks similar to uniQure NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PTGX, PTCT, and PRTA.

Is QURE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5099 seconds.